SYLENTIS S.A.
Company Snapshot
Founded: 2006
Entity Type: Private
Region: Spain
Headquarter: Madrid, Spain
Key Geographics: Spain
Corporate Address: 2 C/ Santiago Grisolía, Tres Cantos, Madrid 28760 Spain Tel. +34-91-804-7667 www.sylentis.com
Company Overview
Sylentis is a pharmaceutical company focused on developing innovative therapies leveraging gene silencing technologies, specifically RNA interference (RNAi). Sylentis has successfully developed numerous therapies based on this cutting-edge technology. Currently, the company has a robust program in ophthalmology, with one candidate, tivanisiran, undergoing Phase III clinical trials for the treatment of dry eye syndrome. Additionally, Sylentis is actively researching and developing new products for the treatment of various eye diseases, including ocular allergies and retinal diseases.
SYLENTIS S.A. In News
Company's Business Segments
- Products : SirFinder.
- Services : Oligonucleotide manufacturing, Oligonucleotide analysis, CDMO Services, Other Services.
Applications/End User Industries
- Healthcare
- Pharmaceuticals
BCC Research Beacon 